● Recruiting

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

Condition: Chronic Lymphocytic Leukemia · CLL · Mantle Cell Lymphoma · Sponsor: BeOne Medicines

PhasePhase 1/Phase 2

Planned participants258

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The purpose of this study is to establish the safety of novel dosing and ramp-up schedules for sonrotoclax in participants with hematological malignancies.

This description comes directly from the study's public registry record.

Talk to the study team

Study Director · 1.877.828.5568 · clinicaltrials@beonemed.com

Study Director

Always discuss trial participation with your own doctor first.

Locations (17)

Moffitt Cancer Center	Tampa, Florida, United States	Active Not Recruiting
Fort Wayne Medical Oncology and Hematology	Fort Wayne, Indiana, United States	Active Not Recruiting
The University of Kansas Cancer Center	Westwood, Kansas, United States	Active Not Recruiting
Dana Farber Cancer Institute	Boston, Massachusetts, United States	Active Not Recruiting
Washington University School of Medicine	St Louis, Missouri, United States	Active Not Recruiting
Fred Hutchinson Cancer Research Center	Seattle, Washington, United States	Active Not Recruiting
Blacktown Cancer and Haematology Centre	Blacktown, New South Wales, Australia	Recruiting
Genesiscare St Andrews	Adelaide, South Australia, Australia	Recruiting
Cabrini Hospital Malvern	Malvern, Victoria, Australia	Recruiting
The Alfred Hospital	Melbourne, Victoria, Australia	Recruiting
Rockingham Hospital	Cooloongup, Western Australia, Australia	Recruiting
Linear Clinical Research	Nedlands, Western Australia, Australia	Recruiting

+ 5 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06697184